Michael Kelliher
Vermögen: 2 Mio $ am 31.05.2026
Vermögen: 2 Mio $ am 31.05.2026
Michael Kelliher currently works at Capricor Therapeutics, Inc., as Independent Director from 2023 and Ardelyx, Inc., as Chief Business Officer from 2025.
Mr. Kelliher also formerly worked at Horizon Therapeutics Ltd. (Ireland), as Group Vice President-Merger & Acquisition.
Mr. Kelliher received his undergraduate degree from University College Cork.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ARDELYX, INC. 0.14% | 21.05.2026 | 357’418 ( 0.14% ) | 2 Mio $ | 31.05.2026 |
| 28.02.2026 | 0 ( -.--% ) | - $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| CAPRICOR THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 01.09.2023 |
| ARDELYX, INC. | Corporate Officer/Principal | 25.03.2024 |
| Unternehmen | Position | Ende |
|---|---|---|
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 4 |
|---|---|
Horizon Therapeutics Ltd. (Ireland)
Horizon Therapeutics Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Discovers, develops and manufactures pharmaceuticals for autoimmune & inflammatory diseases | Health Technology |
University College Cork
University College Cork Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Capricor Therapeutics, Inc.
Capricor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops innovative products for the treatment of cardiovascular diseases | Health Technology |
Ardelyx, Inc.
Ardelyx, Inc. Pharmaceuticals: MajorHealth Technology Discovers and Develops therapeutic therapeutic drugs that work in the gastrointestinal tract to treat cardio-renal, GI and metabolic diseases | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen